<!DOCTYPE html>
<!--[if lt IE 7]>      <html class="no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]-->
<!--[if IE 7]>         <html class="no-js lt-ie9 lt-ie8"> <![endif]-->
<!--[if IE 8]>         <html class="no-js lt-ie9"> <![endif]-->
<!--[if gt IE 8]><!-->
<html class="no-js">
<!--<![endif]-->
<script src="https://cdnjs.cloudflare.com/ajax/libs/jspdf/1.0.272/jspdf.debug.js"></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/html2canvas/0.4.1/html2canvas.js"></script>

<script type="text/javascript" src="https://cdnjs.cloudflare.com/ajax/libs/jspdf/1.2.61/jspdf.min.js"></script>

<head>
<meta http-equiv=Content-Type content="text/html; charset=UTF-8">
<meta name=Generator content="Microsoft Word 14 (filtered)">
<style>
<!--

 p.MsoNormal, li.MsoNormal, div.MsoNormal
    {margin:0in;
    margin-bottom:.0001pt;
    text-autospace:none;
    font-size:12.0pt;
    font-family:"Times New Roman","serif";}
p.MsoCommentText, li.MsoCommentText, div.MsoCommentText
    {mso-style-link:"Comment Text Char";
    margin:0in;
    margin-bottom:.0001pt;
    text-autospace:none;
    font-size:10.0pt;
    font-family:"Times New Roman","serif";}
p.MsoHeader, li.MsoHeader, div.MsoHeader
    {margin:0in;
    margin-bottom:.0001pt;
    text-autospace:none;
    font-size:12.0pt;
    font-family:"Times New Roman","serif";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
    {margin:0in;
    margin-bottom:.0001pt;
    text-autospace:none;
    font-size:12.0pt;
    font-family:"Times New Roman","serif";}
p.MsoCommentSubject, li.MsoCommentSubject, div.MsoCommentSubject
    {margin:0in;
    margin-bottom:.0001pt;
    text-autospace:none;
    font-size:10.0pt;
    font-family:"Times New Roman","serif";
    font-weight:bold;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
    {margin:0in;
    margin-bottom:.0001pt;
    text-autospace:none;
    font-size:8.0pt;
    font-family:"Tahoma","sans-serif";}
span.CommentTextChar
    {mso-style-name:"Comment Text Char";
    mso-style-link:"Comment Text";
    font-family:"Times New Roman","serif";}
 /* Page Definitions */
@page {
  @top-right {
    content: "NCI reference# ____________";
  }
  @bottom-center {
    content: " Page " counter(page) " of " counter(pages);
  }
}
@media all {
    .page-break { display: none; }
}

@media print {
    .page-break { display: block; page-break-before: always; }
}
 ol
    {margin-bottom:0in;}
ul
    {margin-bottom:0in;}
 /*@page-bottom {
   content: "counter(page)";
 }*/
</style>
</head>
<body lang=EN-US style='text-justify-trim:punctuation'style="margin-right:.in height:11in;width:8.5in">
<div style="margin-right:.5in;background-color: white">
	

<p class=MsoNormal align=center style='margin-bottom:12.0pt;text-align:center'><b>SOFTWARE
TRANSFER AGREEMENT</b></p>

<p class=MsoNormal><span style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:11.0pt;margin-left:.5in'>Provider: National
Cancer Institute (NCI)</p>

<p class=MsoNormal style='margin-bottom:8.0pt;margin-left:.5in;'>Recipient: <u>$[Recipient Name]</u></p> 

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal style='margin-bottom:6.0pt'><span style='font-size:11.0pt'>WHEREAS,
Provider has certain proprietary software and associated material described
below (hereinafter, collectively referred to as Software)<i>[Describe all
items being transferred such as; software, executable code, source code,
documentation, data and all other associated materials]</i></span></p>

<p class=MsoNormal><b><span style='font-size:11.0pt;layout-grid-mode:line;text-decoration:underline'>National
Cancer Institute Dosimetry System for Computed Tomography (NCICT) software (NIH
Ref. No. E-082-2016/0), provided as executable code (source code not provided),
a computer program to assess organ radiation dose exposure for pediatric and
adult patients undergoing computed tomography (CT) examinations as described in
Lee et al. (J Radiol Prot. 2015 Dec;35(4):891-909), including further
improvements thereof, and related documentation </span></b></p>

<p class=MsoNormal><span style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><span style='font-size:11.0pt'>and
Provider agrees to transfer such Software to Recipient Investigator, to be used
solely in connection with the following research activity and for the following
reasons (hereinafter Project)<i> [Describe with specificity the scope of use
of Software under this agreement]</i>:</span></p>

<p class=MsoNormal style='text-decoration:underline;margin-left:0.5in'>$[reason]</p><br>


<p class=MsoNormal><span style='font-size:11.0pt;'>NOW, THEREFORE, in
consideration of the premises and mutual covenants contained herein, the
Provider and Recipient agree as follows: </span></p>

<p class=MsoNormal><span style='font-size:11.0pt;'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:9.0pt;margin-bottom:9.0pt
text-indent:-.25in'><span style='font-size:11.0pt'>1.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
style='font-size:11.0pt'>SOFTWARE SHALL NOT BE USED FOR TREATING OR DIAGNOSING
HUMAN SUBJECTS.   </span></p>

<!-- 

<p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:9.0pt;
margin-left:.5in;text-indent:-.25in'><span style='font-size:11.0pt'>2.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
style='font-size:11.0pt'>
-->
<p class=MsoNormal style='font-size:11.0pt;margin-bottom:9.0pt '><span>2.
Recipient will not license or sell or use Software for commercial purposes or applications. 
 Recipient Investigator shall retain control over Software and further will not transfer 
 the Software to individuals not under Recipient Investigator’s direct supervision 
 without the advance written approval of Provider.  
 Recipient agrees to comply with all regulations applicable to the Project and the use of the Software.  </span></p>

<p class=MsoNormal style='margin-bottom:9.0pt'><span style='font-size:11.0pt'>2.   Recipient
agrees not to copy Software, in whole or in part, except as required for use by 
Recipient Investigator for the conduct of the Project. Recipient shall not modify, 
extend, decompile, make derivatives of or reverse engineer the Software without written permission from Provider.</span></p>

<p class=MsoNormal style='margin-bottom:9.0pt'><span style='font-size:11.0pt'>3.   Information
deemed confidential under this Agreement (“Confidential Information”) shall be clearly marked “CONFIDENTIAL.”  
Any information that is orally disclosed must be reduced to writing and marked “CONFIDENTIAL” 
by the provider of the information within thirty (30) days of such disclosure. 
To the extent permitted by applicable law, the Recipient agrees to employ all reasonable 
efforts to safeguard Provider’s Confidential Information to 
ensure that no unauthorized person shall have access thereto and that no unauthorized copy, 
publication, disclosure or distribution, in whole or in part, in any form shall be made.</span></p>

<p class=MsoNormal style='margin-bottom:9.0pt'><span style='font-size:11.0pt'>4.    
In all oral presentations or written publications concerning the Project, 
Recipient will acknowledge Provider’s contribution of Software unless requested otherwise.  
Recipient may publish or otherwise publicly disclose the results of the Project, 
but if Provider has given Confidential Information to Recipient, 
such public disclosure may be made only after Provider has had 30 days to review the proposed disclosure, 
except when a shortened time period under court order or the Freedom of Information Act pertains.</span></p>

<span style='font-size:11.0pt;font-family:"Times New Roman","serif"'><br
clear=all style='page-break-before:auto'>
</span>


<p class=MsoNormal style='margin-bottom:3.0pt'><span style='font-size:11.0pt'>5.   The
obligations of Recipient under Paragraph 4 above shall not extend to any part
of the Confidential Information:</span></p>

<p class=MsoNormal style='margin-bottom:3.0pt;margin-left:.5in'><span
style='font-size:11.0pt' > (a) that can be demonstrated to have been publicly
known at the time of disclosure; or</span></p>

<p class=MsoNormal style='margin-bottom:3.0pt;margin-left:.5in'><span
style='font-size:11.0pt'>(b) that can be demonstrated to have been properly in
the Recipients possession or that can be demonstrated to have been readily
available to the Recipient from another proper source prior to the disclosure;
or</span></p>

<p class=MsoNormal style='margin-bottom:3.0pt;margin-left:.5in'><span
style='font-size:11.0pt'>(c) that becomes part of the public domain or publicly
known by publication or otherwise, not due to any unauthorized act by the
Recipient or its subsidiaries; or</span></p>

<p class=MsoNormal style='margin-bottom:3.0pt;margin-left:.5in'><span
style='font-size:11.0pt'>(d) that can be demonstrated as independently
developed or acquired by the Recipient without reference to or reliance upon
such information; or</span></p>

<p class=MsoNormal style='margin-bottom:9.0pt;margin-left:.5in'><span
style='font-size:11.0pt'>(e) that is required to be disclosed by law, provided
that the Recipient takes reasonable and lawful actions to avoid and/or minimize
such disclosure.</span></p>

<p class=MsoNormal style='margin-bottom:9.0pt'><span style='font-size:11.0pt'>6.   The
Recipient's obligations under Paragraphs 4 and 5 shall extend for a period of
three (3) years from the date of disclosure.</span></p>

<p class=MsoNormal style='margin-bottom:9.0pt'><span style='font-size:11.0pt'>7.   Title
in the Software shall remain with the Provider.  It is understood that nothing
herein shall be deemed to constitute, by implication or otherwise, the grant to
either Party by the other of any license or other rights under any patent,
patent application or other intellectual property right or interest.  Provider
reserves the right to distribute Software to others and to use it for
Provider's own purposes.   </span></p>

<p class=MsoNormal style='margin-bottom:9.0pt'><span style='font-size:11.0pt'>8.   When
the Project is completed or this Agreement is terminated, whichever occurs
first, Recipient will destroy all copies of Software and Providers
Confidential Information unless directed otherwise by Provider in writing.</span></p>

<p class=MsoNormal style='margin-bottom:9.0pt'><span style='font-size:11.0pt'>9.   This
Agreement may be terminated by either Recipient or Provider by providing 30
days advance notice.</span></p>

<p class=MsoNormal style='margin-bottom:9.0pt'><span style='font-size:11.0pt'>10.  The
Provider and Recipient each shall retain title to any patent or other
intellectual property of their respective employees developed or created in the
course of the Project defined in this Agreement. Neither Provider nor Recipient
promise rights in advance for inventions developed under this Agreement.</span></p>

<p class=MsoNormal style='margin-bottom:9.0pt'><span style='font-size:11.0pt'>11.  No
indemnification for any loss, claim, damage, or liability is intended or
provided by any party under this agreement. Each party shall be liable for any
loss, claim, damage, or liability that said party incurs as a result of said
party's activities under this agreement, except that the NIH, as an agency of
the United States, assumes liability only to the extent as provided under the United
States Federal Tort Claims Act (28 U.S.C. Chapter 171). </span></p>

<p class=MsoNormal style='margin-bottom:9.0pt'><span style='font-size:11.0pt'>12.  Software
is supplied AS IS, without any accompanying services or improvements from
Provider. SOFTWARE IS SUPPLIED TO RECIPIENT WITH NO WARRANTIES, EXPRESS OR
IMPLIED, INCLUDING ANY WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR
PURPOSE.  Provider makes no representations that the use of Software will not
infringe any patent or proprietary rights of third parties.</span></p>

<p class=MsoNormal style='margin-bottom:4.0pt'><b>&nbsp;</b></p>

<p class=MsoNormal style='margin-bottom:4.0pt'><b>&nbsp;</b></p>

<p class=MsoNormal align=center style='margin-bottom:4.0pt;text-align:center'><b>Signatures
Begin on Next Page</b></p>
<div class="page-break">
    <p class=MsoNormal style='margin-bottom:4.0pt'><b>For Recipient</b>:</p>

<p class=MsoNormal><span style='font-size:11.0pt'>Authorized Official for
Recipient:</span></p><br>

<p class=MsoNormal><span style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span style='font-size:11.0pt'>______________________________________________      
_________________</span></p>

<p class=MsoNormal style="float:right;margin-right:1.5in"><span style='font-size:11.0pt'>Date </span></p>
<p class=MsoNormal><span lang=FR style='font-size:11.0pt;layout-grid-mode:line'>$[Recipient Name_sig]</span><span lang=FR style='layout-grid-mode:line'></span><span
style='font-size:11.0pt'></span></p>

<p class=MsoNormal><span style='font-size:11.0pt'>$[Recipient Title_sig] </span></p>



<p class=MsoNormal><span style='font-size:11.0pt'>&nbsp;</span></p><br>

<p class=MsoNormal><span style='font-size:11.0pt'>Read and Understood by
Recipient Investigator:</span></p><br>

<p class=MsoNormal><span style='font-size:11.0pt'>______________________________________________      
_________________</span></p>

<p class=MsoNormal style="float:right;margin-right:1.5in"><span style='font-size:11.0pt'>Date </span></p>
<p class=MsoNormal><span lang=FR style='font-size:11.0pt;layout-grid-mode:line'>$[Investigator Name]</span><span lang=FR style='layout-grid-mode:line'></span><span
style='font-size:11.0pt'></span></p>
<p class=MsoNormal><span style='font-size:11.0pt'>$[Investigator Title] </span></p><br><br>


<p class=MsoNormal><span style='font-size:11.0pt'>Mailing Address for Legal Notices:</span></p><br>
<p class=MsoNormal style='margin-left:.5in;font-size:11.0pt'>$[Mailing Address]</p><br>


<p class=MsoNormal style='margin-left:.5in'><span style='font-size:11.0pt'>Phone: $[phone] &nbsp; Fax: $[fax]</span></p><br><br>
<p class=MsoNormal><b>For Provider</b>:</p>

<p class=MsoNormal><span style='font-size:11.0pt'>Authorized Official for
Provider:</span></p><br><br>


<p class=MsoNormal><span style='font-size:11.0pt'>______________________________________________      
_________________</span></p>

<p class=MsoNormal style="float:right;margin-right:1.5in"><span style='font-size:11.0pt'>Date </span></p>
<p class=MsoNormal><span lang=FR style='font-size:11.0pt;layout-grid-mode:line'>Name:</span><span lang=FR style='layout-grid-mode:line'></span><span
style='font-size:11.0pt'></span></p>
<p class=MsoNormal><span style='font-size:11.0pt'>Title:</span></p><br><br>

<p class=MsoNormal><span style='font-size:11.0pt'>Read and Understood by
Provider's Investigator:</span></p><br><br>



<p class=MsoNormal><span style='font-size:11.0pt'>______________________________________________    
_________________</span></p>

<p class=MsoNormal style="float:right;margin-right:1.5in"><span style='font-size:11.0pt'>Date </span></p>
<p class=MsoNormal><span lang=FR style='font-size:11.0pt;layout-grid-mode:line'>Dr.
Choonsik Lee</span><span lang=FR style='layout-grid-mode:line'></span><span
style='font-size:11.0pt'></span></p>
<p class=MsoNormal><span style='font-size:11.0pt'>Investigator </span></p>

<p class=MsoNormal><span style='font-size:11.0pt'>Radiation Epidemiology Branch
</span></p>

<p class=MsoNormal><span style='font-size:11.0pt'>Division of Cancer
Epidemiology &amp; Genetics, NCI</span></p>

<p class=MsoNormal><span style='font-size:11.0pt'>Provider's Mailing Address
for Legal Notices:</span></p>

<p class=MsoNormal style='margin-left:.25in'><span style='font-size:11.0pt'>National
Institutes of Health</span></p>

<p class=MsoNormal style='margin-left:.25in'><span style='font-size:11.0pt'>National
Cancer Institute</span></p>

<p class=MsoNormal style='margin-left:.25in'><span style='font-size:11.0pt'>Technology
Transfer Center</span></p>

<p class=MsoNormal style='margin-left:.25in'><span style='font-size:11.0pt'>9609
Medical Center Dr Rm 1E530, MSC 9702</span></p>

<p class=MsoNormal style='margin-left:.25in'><span style='font-size:11.0pt'>Bethesda,
MD 20892-9702</span></p>

<p class=MsoNormal style='margin-left:.25in'><span style='font-size:11.0pt'>Phone:
240-276-5530           Fax: 240-276-5504</span></p>
</div>

</div>
</body>

</html>
